瘦肉精监测卡 返回列表页

美国Alfa 瘦肉精监测卡

广州健仑生物科技有限公司

我司长期供应瘦肉精三联检测卡，本产品用于快速检测动物尿样、组织和饲料中盐酸克伦特罗、莱克多巴胺、沙丁胺醇残留，整个检测过程只需要3-5分钟左右，具有操作简单，方便快捷，灵敏度高特异性强等特点。

瘦肉精检测试剂进口品牌：美国Alfa、美国US

我司还提供其它进口或国产试剂盒：登革热、疟疾、流感、A链球菌、合胞病毒、腮病毒、乙脑、寨卡、黄热病、基孔肯雅热、克锥虫病、违禁品滥用、肺炎球菌、军团菌、化妆品检测、食品安全检测等试剂盒以及日本生研细菌分型诊断血清、德国SiFin诊断血清、丹麦SSI诊断血清等产品。

欢迎咨询

欢迎咨询2042552662

瘦肉精检测试剂盒、瘦肉精检测试剂、瘦肉精检测卡、瘦肉精检测试纸、瘦肉精快速检测卡、瘦肉精三联检测卡、盐酸克伦特罗检测卡、莱克多巴胺检测卡、沙丁胺醇检测卡

【瘦肉精的危害】

“瘦肉精”进入动物体内后主要分布于肝脏。肌肉中含量较肝脏低很多。人摄入后在体内存留时间较长，其不良反应主要有：可引起心率加速，特别是原有心律失常的病例更易发生心脏反应，可见心室早搏、ST段与T波幅压低，还会发出肌肉震颤，引发四肢、面颈部骨骼肌震颤，尤其是交感神经功能亢进的病例更易发生。此外，还可引起代谢紊乱、血钾降低，引起心慌、肌肉震颤、头痛以及脸部潮红等。对心率失常、高血压、青光眼、糖尿病、甲状腺机能亢进等疾病的患者有较大危害。

美国Alfa 瘦肉精监测卡

【产品简介】

本产品为克伦特罗-莱克多巴胺-沙丁胺醇三合一胶体金快速检测卡，用于定性检测猪、牛、羊尿液、组织和饲料中的瘦肉精残留，整个检测过程只需要3-5分钟左右。

【检测限】

克伦特罗3ng/ml（3ppb），莱克多巴胺3ng/ml（3ppb），沙丁胺醇3ng/ml（3ppb）

【产品组成】

克伦特罗-莱克多巴胺-沙丁胺醇三合一胶体金快速检测卡（40T/盒）

滴管（1个/袋）、干燥剂（1片/袋）

【样品处理】

用干燥、洁净的离心管或适当容器采集50ml左右尿液。如果不立即检测，待检样本在2-8℃存放，可保存24小时，注意避免腐坏造成失效或污染。出现阳性结果应按法定程序分瓶封装样品用于确证法检测。

【使用步骤】

1、测试前先完整阅读说明书，使用前将检测卡和待检样本溶液恢复至室温4～30℃。

2、从原包装袋中取出检测卡，打开后请在一个小时内尽快地使用。

3、将检测卡平放，用滴管吸取待检样品溶液，缓慢垂直滴加2-3滴于加样孔中，加样后开始计时。

4、结果应在3-5分钟时读取，其他时间判读无效，根据示意图判定结果。

【结果判断】

1. 阴性（-）：两条紫红色条带出现。表示样品中不含有瘦肉精或其浓度低于检测限。
2. 阳性（+）：检测T线无显色，则表示样品中瘦肉精浓度高于检测限。

1. 无效：未出现质控C线，表明操作过程不正确或检测卡已失效。

【注意事项】

1、检测卡请在保质期内一次性使用；

2、检测时避免阳光直射和电风扇直吹；

3、尽量不要触摸检测卡中央的白色膜面；

4、采样滴管不可混用，以免交叉污染；

5、如果待检样本出现沉淀或浑浊物，请离心后再检测；

6、试验遇到的任何问题，请与供应商。

【储存及有效期】

原包装应储存于4～40℃，阴凉避光干燥处，切勿冷冻；有效期24个月。有效期及批号见外包装。

美国Alfa

2009年，随着医药行业专项整治可能带来的市场规范化程度提升、新医改方案带来市场扩容机会、新上市产品的增加、药品终端需求活跃以及新一轮投资热潮等众多有利因素将保证中国医药行业继续快速增长。但随着金融危机的蔓延和世界经济的减速，中国医药外贸面临的形势更加严峻。2009年有可能是进入新世纪以来zui为困难的一年。但是由于中国医药行业的特点以及新医改对内需的拉动作用，中国医药进出口总额有望继续保持一定的增长。“变压力为动力、化挑战为机遇”将成为2009年中国医药外贸发展的主旋律。
药水
药水
展望未来，中国医药行业景气才刚刚开始，未来提升空间巨大。医药产业进入新医改牵引下的新一轮有序发展期。未来新医改方案将对中国医药行业的市场结构、产业结构、产品结构等方面产生深刻的影响，到2010年，医改带来的药品增量至少在1000亿以上，加上行业自然增长部分，预计未来3-5年医药行业的年增长率不会低于20%。
中药情景
整个中药材产需及市场供求关系将发生以下变化：
1、生产相对稳定，货源紧中有松。随着我国农村产业结构初见成效，粮棉总量调减，优质品种增加，市价略有回升，各种经济作物亦按照市场需求进行调整，作为农付产品的中药材，自1997年下半年出现总体减少，价格一路下滑，至今已持续三年多,由于药价偏低，药材生产大多微利或低于生产成本，使药农的种植积极性大打折扣。同时药农痛定思痛，吸取教训，开始面向市场有的放失发展生产，压缩那些滞销积压的品种面积，扩大市场紧俏*的品种生产面积，经过几年的市场调节与生产调整，药材市场的供求关系开始趋向合理，据有关资料显示，近一二年全国家种面积一直保持在37-40万公顷之间波动，尤其山东、江苏、陕西、云南、贵州、安徽、山西等省份发展迅猛。预计年内常用大宗品种，如桔梗、板兰根、生地黄、白芷、牛膝、玄参、白药、太子参、红花、川芎、党参、北沙参等品种因受前几年市场“高炒”价格跌至近几年来的谷底的影响，生产出现不同程度的违禁品，市场行情正处于由低向高运行的转折点，随着历年库存的消耗，这些品种价格可望发生逆转。少部分多年生品种如山茱萸、黄连等品种因多种因素影响,供求矛盾尚难好转,货源将日益紧缺。大茴、小良姜、山萘、丁香、草果等药食兼用的香料药材品种，因其价格偏高，按市场规律 。

美国Alfa

我司还提供其它进口或国产试剂盒：登革热、疟疾、流感、A链球菌、合胞病毒、腮病毒、乙脑、寨卡、黄热病、基孔肯雅热、克锥虫病、违禁品滥用、肺炎球菌、军团菌、食品安全、化妆品检测、药物滥用检测等试剂盒以及日本生研细菌分型诊断血清、德国SiFin诊断血清、丹麦SSI诊断血清等产品。

想了解更多的产品及服务请扫描下方二维码：

【公司名称】 广州健仑生物科技有限公司
【市场部】    杨永汉

【】 
【腾讯  】 2042552662
【公司地址】 广州清华科技园创新基地番禺石楼镇创启路63号二期2幢101-103室

In 2009, with the standardization of the market brought by special rectification by the pharmaceutical industry, the new healthcare reform program will bring about opportunities for expansion of the market. The favorable factors such as the increase of new listings, the active demand of pharmaceutical terminals and the new round of investment boom will ensure that China The pharmaceutical industry continues to grow rapidly. However, with the spread of the financial crisis and the slowdown of the world economy, the situation facing China's pharmaceutical foreign trade is even more severe. 2009 may be the most difficult year since entering the new century. However, due to the characteristics of China's pharmaceutical industry and the stimulating effect of the new medical reform on domestic demand, the total volume of China's pharmaceutical exports and imports is expected to continue to grow at a certain rate. "Transforming pressure into motivation and turning challenges into opportunities" will become the main theme of the development of China's pharmaceutical foreign trade in 2009.
Potion
Potion
Looking to the future, the prosperity of China's pharmaceutical industry has just begun, huge room for improvement in the future. The pharmaceutical industry has entered a new round of orderly development under the guidance of new medical reform. The new medical reform plan in the future will have a profound impact on the market structure, industrial structure and product structure of China's pharmaceutical industry. By 2010, the increase in pharmaceuticals brought by medical reform will be at least 100 billion or more. Coupled with the natural growth of the industry, The next three to five years the pharmaceutical industry will not be less than 20% annual growth rate.
Chinese scene
The entire Chinese herbal medicine production and demand and market supply and demand will occur the following changes:
1, the production is relatively stable, tight supply tight. With the initial success of China's rural industrial structure, the total amount of grain and cotton decreased, the quality of varieties increased, the market price rebounded slightly, and various cash crops were also adjusted according to market demand. As the traditional Chinese medicines for agricultural products, since the second half of 1997 As a whole, the prices have been decreasing and the price has been falling all the way. It has lasted for more than three years. Due to the low price of medicines, the production of medicinal herbs is mostly at a low profit or below the production cost, which greatly reduces the enthusiasm of the farmers. At the same time, medicine and agricultural science and thinking pain, learn a lesson, some market-oriented start to lose the development of production, compression of those who sell off the backlog of varieties of area, expanding the market tight and profitable production area, after years of market regulation and production adjustment, medicine market supply and demand The trend is reasonable. According to relevant statistics, the total area of ​​family-owned species in the country has fluctuated between 3,700,000 and 4,000 hectares in recent one or two years. In particular, the provinces of Shandong, Jiangsu, Shaanxi, Yunnan, Guizhou, Anhui and Shanxi have been developing rapidly. It is estimated that the varieties commonly used during the year such as Campanulaceae, Radix, Radix Rehmanniae, Angelica, Achyranthes, Scrophulariaceae, Baiyao, heterophylla, safflower, Chuanxiong, Codonopsis, Pak Sanshen varieties due to the market a few years ago, "speculation" price Fell to the bottom in recent years, the impact of the production of varying degrees of contraband, the market is at a turning point from low to high, with the depletion of inventory over the years, these varieties are expected to reverse the price. A small number of perennial varieties such as dogwood, berberine and other varieties due to many factors, the supply and demand is still difficult to improve the contradiction between supply will increasingly scarce. Fennel, small galangal, naphthalene, cloves, grass and other medicinal herbs and spices spices, because of their high prices, according to market rules.